Enigma Biomedical USA and the University of WisconsinMadison announce Formation of a Partnership to Advance Development of Next-Generation Imaging and Fluid Biomarkers for Improved Understanding and Management of Neurodegenerative Diseases

KNOXVILLE, Tenn. — Enigma Biomedical USA, Inc (Enigma) and the University of Wisconsin–Madison (UW–Madison) today announced formation of a partnership focused on development of next-generation Positron Emission Tomography (PET) Imaging and fluid biomarkers. Enigma will support this work at the new Biomarker Development Lab for Age-related Neurodegenerative Disease at the UW School of Medicine and […]

Read Full Article